dc.contributor.author | Arbab, Mandana | |
dc.contributor.author | Srinivasan, Sharanya | |
dc.contributor.author | Geijsen, Niels | |
dc.contributor.author | Sherwood, Richard I. | |
dc.contributor.author | Hashimoto, Tatsunori Benjamin | |
dc.date.accessioned | 2016-01-13T16:56:19Z | |
dc.date.available | 2016-01-13T16:56:19Z | |
dc.date.issued | 2015-10 | |
dc.date.submitted | 2015-09 | |
dc.identifier.issn | 22136711 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/100809 | |
dc.description.abstract | We present self-cloning CRISPR/Cas9 (scCRISPR), a technology that allows for CRISPR/Cas9-mediated genomic mutation and site-specific knockin transgene creation within several hours by circumventing the need to clone a site-specific single-guide RNA (sgRNA) or knockin homology construct for each target locus. We introduce a self-cleaving palindromic sgRNA plasmid and a short double-stranded DNA sequence encoding the desired locus-specific sgRNA into target cells, allowing them to produce a locus-specific sgRNA plasmid through homologous recombination. scCRISPR enables efficient generation of gene knockouts (∼88% mutation rate) at approximately one-sixth the cost of plasmid-based sgRNA construction with only 2 hr of preparation for each targeted site. Additionally, we demonstrate efficient site-specific knockin of GFP transgenes without any plasmid cloning or genome-integrated selection cassette in mouse and human embryonic stem cells (2%–4% knockin rate) through PCR-based addition of short homology arms. scCRISPR substantially lowers the bar on mouse and human transgenesis. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (5UL1DE019581) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (RL1DE019021) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (1K01DK101684-01) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (1U01HG007037) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (5P01NS055923) | en_US |
dc.description.sponsorship | Harvard Stem Cell Institute (Sternlicht Director's Fund Award) | en_US |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.stemcr.2015.09.022 | en_US |
dc.rights | Creative Commons Attribution | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | Elsevier | en_US |
dc.title | Cloning-free CRISPR | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Arbab, Mandana, Sharanya Srinivasan, Tatsunori Hashimoto, Niels Geijsen, and Richard I. Sherwood. “Cloning-Free CRISPR.” Stem Cell Reports 5, no. 5 (November 2015): 908–917. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science | en_US |
dc.contributor.mitauthor | Srinivasan, Sharanya | en_US |
dc.contributor.mitauthor | Hashimoto, Tatsunori Benjamin | en_US |
dc.relation.journal | Stem Cell Reports | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Arbab, Mandana; Srinivasan, Sharanya; Hashimoto, Tatsunori; Geijsen, Niels; Sherwood, Richard I. | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-0521-5855 | |
mit.license | OPEN_ACCESS_POLICY | en_US |